28/10/10

SHARP Study Results

SHARP Study Results

The results of the Study of Heart And Renal Protection (SHARP) will be presented at the late-breaking clinical trials session at the American Society of Nephrology in Denver on Saturday 20th November 2010 at 1205 pm in the Wells Fargo Theatre. SHARP is the largest double-blind randomized controlled trial in patients with CKD to date. It enrolled 9438 participants in 18 countries, of whom approximately two-thirds were pre-dialysis at the time of recruitment. It aims to assess the effects of cholesterol-lowering therapy with a combination of simvastatin and the cholesterol absorption inhibitor ezetimibe on cardiovascular and renal outcomes.